Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection

Microdose flare-up GnRH agonist and GnRH antagonist have become more popular in the management of poor ovarian responders (POR) in recent years; however, the optimal protocol for POR patients undergoing in vitro fertilization has still been a challenge. In this observational study design, two hundre...

Full description

Saved in:
Bibliographic Details
Published in:Journal of reproduction & infertility 2016-07, Vol.17 (3), p.163-168
Main Authors: Boza, Aysen, Cakar, Erbil, Boza, Barıs, Api, Murat, Kayatas, Semra, Sofuoglu, Kenan
Format: Article
Language:English
Subjects:
Original
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 168
container_issue 3
container_start_page 163
container_title Journal of reproduction & infertility
container_volume 17
creator Boza, Aysen
Cakar, Erbil
Boza, Barıs
Api, Murat
Kayatas, Semra
Sofuoglu, Kenan
description Microdose flare-up GnRH agonist and GnRH antagonist have become more popular in the management of poor ovarian responders (POR) in recent years; however, the optimal protocol for POR patients undergoing in vitro fertilization has still been a challenge. In this observational study design, two hundred forty four poor ovarian responders were retrospectively evaluated for their response to GnRH agonist protocol (group-1, n=135) or GnRH antagonist protocol (group-2, n=109). Clinical pregnancy rate was the primary end point and was compared between the groups. Student t-test, Mann Whitney U test and χ (2)-test were used to compare the groups. The p
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4947204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808376718</sourcerecordid><originalsourceid>FETCH-LOGICAL-p181t-76b925d327abaa163aae0e73ca840ffa7b8527f78a5f59635185cb43ae159f23</originalsourceid><addsrcrecordid>eNpVkdFq3TAMhsNYWUvbVxi-7C4CsR3Hzs3gUNZzCh0tXVt2FxRHOXNJrMx2Cn2jPuYSdjY23Uj8kr5foHfZiRCK55Wuvr9fa2FyVRpxnJ3H-FwsUddcyPpDdix0qY3WxUn29tXZQB1FZFcDBMzniW3JQ0cp0OR8HnBAiM7v2Y7CSB7Zxdbf7z6xzZ68i4k9YYhzZKvINj7BQb4LlMjSEJnz7I4osNsXCA48u8c4ke-WNfa4pj2t9GufAtjXRNMAcXSWfZswjIv8jDY58mfZUQ9DxPNDPs0err48XO7ym9vt9eXmJp-44SnXVVsL1UmhoQXglQTAArW0YMqi70G3RgndawOqV3UlFTfKtqUE5KruhTzNPv_GTnM7YmdxPWtopuBGCK8NgWv-73j3o9nTS1PWpRZFuQAuDoBAP2eMqRldtDgM4JHm2HBTGKkrzc0y-vFfr78mf74jfwGcrpKL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808376718</pqid></control><display><type>article</type><title>Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection</title><source>PubMed Central</source><creator>Boza, Aysen ; Cakar, Erbil ; Boza, Barıs ; Api, Murat ; Kayatas, Semra ; Sofuoglu, Kenan</creator><creatorcontrib>Boza, Aysen ; Cakar, Erbil ; Boza, Barıs ; Api, Murat ; Kayatas, Semra ; Sofuoglu, Kenan</creatorcontrib><description>Microdose flare-up GnRH agonist and GnRH antagonist have become more popular in the management of poor ovarian responders (POR) in recent years; however, the optimal protocol for POR patients undergoing in vitro fertilization has still been a challenge. In this observational study design, two hundred forty four poor ovarian responders were retrospectively evaluated for their response to GnRH agonist protocol (group-1, n=135) or GnRH antagonist protocol (group-2, n=109). Clinical pregnancy rate was the primary end point and was compared between the groups. Student t-test, Mann Whitney U test and χ (2)-test were used to compare the groups. The p&lt;0.05 was considered to show a statistically significant result. The mean total gonadotropin doses were 3814±891 IU in group 1 and 3539±877 IU in group 2 (p=0.02). The number of metaphase-II oocytes (3.6±2.4 vs. 2.8±1.9, p=0.005) and implantation rates (27.8% vs. 18.8%, p=0.04) in group 1 and group 2, respectively were significantly different. The fertilization rate in group 1 and group 2 was 73% vs. 68%, respectively (p=0.5) and clinical pregnancy rate was 19.8% vs. 14.4%, respectively (p=0.13). The GnRH agonist microdose flare-up protocol has favorable outcomes with respect to the number of oocytes retrieved and implantation rate; nevertheless, the clinical pregnancy rate was found to be similar in comparison to GnRH antagonist protocol in poor ovarian responders. GnRH antagonist protocol appears to be promising with significantly lower gonadotropin requirement and lower treatment cost in poor ovarian responders.</description><identifier>ISSN: 2228-5482</identifier><identifier>EISSN: 2251-676X</identifier><identifier>PMID: 27478770</identifier><language>eng</language><publisher>Iran: Avicenna Research Institute</publisher><subject>Original</subject><ispartof>Journal of reproduction &amp; infertility, 2016-07, Vol.17 (3), p.163-168</ispartof><rights>Copyright© 2016, Avicenna Research Institute. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947204/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947204/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27478770$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boza, Aysen</creatorcontrib><creatorcontrib>Cakar, Erbil</creatorcontrib><creatorcontrib>Boza, Barıs</creatorcontrib><creatorcontrib>Api, Murat</creatorcontrib><creatorcontrib>Kayatas, Semra</creatorcontrib><creatorcontrib>Sofuoglu, Kenan</creatorcontrib><title>Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection</title><title>Journal of reproduction &amp; infertility</title><addtitle>J Reprod Infertil</addtitle><description>Microdose flare-up GnRH agonist and GnRH antagonist have become more popular in the management of poor ovarian responders (POR) in recent years; however, the optimal protocol for POR patients undergoing in vitro fertilization has still been a challenge. In this observational study design, two hundred forty four poor ovarian responders were retrospectively evaluated for their response to GnRH agonist protocol (group-1, n=135) or GnRH antagonist protocol (group-2, n=109). Clinical pregnancy rate was the primary end point and was compared between the groups. Student t-test, Mann Whitney U test and χ (2)-test were used to compare the groups. The p&lt;0.05 was considered to show a statistically significant result. The mean total gonadotropin doses were 3814±891 IU in group 1 and 3539±877 IU in group 2 (p=0.02). The number of metaphase-II oocytes (3.6±2.4 vs. 2.8±1.9, p=0.005) and implantation rates (27.8% vs. 18.8%, p=0.04) in group 1 and group 2, respectively were significantly different. The fertilization rate in group 1 and group 2 was 73% vs. 68%, respectively (p=0.5) and clinical pregnancy rate was 19.8% vs. 14.4%, respectively (p=0.13). The GnRH agonist microdose flare-up protocol has favorable outcomes with respect to the number of oocytes retrieved and implantation rate; nevertheless, the clinical pregnancy rate was found to be similar in comparison to GnRH antagonist protocol in poor ovarian responders. GnRH antagonist protocol appears to be promising with significantly lower gonadotropin requirement and lower treatment cost in poor ovarian responders.</description><subject>Original</subject><issn>2228-5482</issn><issn>2251-676X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpVkdFq3TAMhsNYWUvbVxi-7C4CsR3Hzs3gUNZzCh0tXVt2FxRHOXNJrMx2Cn2jPuYSdjY23Uj8kr5foHfZiRCK55Wuvr9fa2FyVRpxnJ3H-FwsUddcyPpDdix0qY3WxUn29tXZQB1FZFcDBMzniW3JQ0cp0OR8HnBAiM7v2Y7CSB7Zxdbf7z6xzZ68i4k9YYhzZKvINj7BQb4LlMjSEJnz7I4osNsXCA48u8c4ke-WNfa4pj2t9GufAtjXRNMAcXSWfZswjIv8jDY58mfZUQ9DxPNDPs0err48XO7ym9vt9eXmJp-44SnXVVsL1UmhoQXglQTAArW0YMqi70G3RgndawOqV3UlFTfKtqUE5KruhTzNPv_GTnM7YmdxPWtopuBGCK8NgWv-73j3o9nTS1PWpRZFuQAuDoBAP2eMqRldtDgM4JHm2HBTGKkrzc0y-vFfr78mf74jfwGcrpKL</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Boza, Aysen</creator><creator>Cakar, Erbil</creator><creator>Boza, Barıs</creator><creator>Api, Murat</creator><creator>Kayatas, Semra</creator><creator>Sofuoglu, Kenan</creator><general>Avicenna Research Institute</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160701</creationdate><title>Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection</title><author>Boza, Aysen ; Cakar, Erbil ; Boza, Barıs ; Api, Murat ; Kayatas, Semra ; Sofuoglu, Kenan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p181t-76b925d327abaa163aae0e73ca840ffa7b8527f78a5f59635185cb43ae159f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boza, Aysen</creatorcontrib><creatorcontrib>Cakar, Erbil</creatorcontrib><creatorcontrib>Boza, Barıs</creatorcontrib><creatorcontrib>Api, Murat</creatorcontrib><creatorcontrib>Kayatas, Semra</creatorcontrib><creatorcontrib>Sofuoglu, Kenan</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of reproduction &amp; infertility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boza, Aysen</au><au>Cakar, Erbil</au><au>Boza, Barıs</au><au>Api, Murat</au><au>Kayatas, Semra</au><au>Sofuoglu, Kenan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection</atitle><jtitle>Journal of reproduction &amp; infertility</jtitle><addtitle>J Reprod Infertil</addtitle><date>2016-07-01</date><risdate>2016</risdate><volume>17</volume><issue>3</issue><spage>163</spage><epage>168</epage><pages>163-168</pages><issn>2228-5482</issn><eissn>2251-676X</eissn><abstract>Microdose flare-up GnRH agonist and GnRH antagonist have become more popular in the management of poor ovarian responders (POR) in recent years; however, the optimal protocol for POR patients undergoing in vitro fertilization has still been a challenge. In this observational study design, two hundred forty four poor ovarian responders were retrospectively evaluated for their response to GnRH agonist protocol (group-1, n=135) or GnRH antagonist protocol (group-2, n=109). Clinical pregnancy rate was the primary end point and was compared between the groups. Student t-test, Mann Whitney U test and χ (2)-test were used to compare the groups. The p&lt;0.05 was considered to show a statistically significant result. The mean total gonadotropin doses were 3814±891 IU in group 1 and 3539±877 IU in group 2 (p=0.02). The number of metaphase-II oocytes (3.6±2.4 vs. 2.8±1.9, p=0.005) and implantation rates (27.8% vs. 18.8%, p=0.04) in group 1 and group 2, respectively were significantly different. The fertilization rate in group 1 and group 2 was 73% vs. 68%, respectively (p=0.5) and clinical pregnancy rate was 19.8% vs. 14.4%, respectively (p=0.13). The GnRH agonist microdose flare-up protocol has favorable outcomes with respect to the number of oocytes retrieved and implantation rate; nevertheless, the clinical pregnancy rate was found to be similar in comparison to GnRH antagonist protocol in poor ovarian responders. GnRH antagonist protocol appears to be promising with significantly lower gonadotropin requirement and lower treatment cost in poor ovarian responders.</abstract><cop>Iran</cop><pub>Avicenna Research Institute</pub><pmid>27478770</pmid><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2228-5482
ispartof Journal of reproduction & infertility, 2016-07, Vol.17 (3), p.163-168
issn 2228-5482
2251-676X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4947204
source PubMed Central
subjects Original
title Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T09%3A17%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microdose%20Flare-up%20Gonadotropin-releasing%20Hormone%20(GnRH)%20Agonist%20Versus%20GnRH%20Antagonist%20Protocols%20in%20Poor%20Ovarian%20Responders%20Undergoing%20Intracytoplasmic%20Sperm%20Injection&rft.jtitle=Journal%20of%20reproduction%20&%20infertility&rft.au=Boza,%20Aysen&rft.date=2016-07-01&rft.volume=17&rft.issue=3&rft.spage=163&rft.epage=168&rft.pages=163-168&rft.issn=2228-5482&rft.eissn=2251-676X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1808376718%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p181t-76b925d327abaa163aae0e73ca840ffa7b8527f78a5f59635185cb43ae159f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1808376718&rft_id=info:pmid/27478770&rfr_iscdi=true